+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Melanoma"

Oncology Collaboration and Licensing Deals 2020-2025 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2020-2025

  • Report
  • April 2025
  • 1500 Pages
  • Global
From
From
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • April 2025
  • 224 Pages
  • Global
From
Cancer Supportive Care Products Market Report 2025 - Product Thumbnail Image

Cancer Supportive Care Products Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Oncology Biomarkers Market Report 2025 - Product Thumbnail Image

Oncology Biomarkers Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anti-Cancer MAbS Market Report 2025 - Product Thumbnail Image

Anti-Cancer MAbS Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Cancer Biopsy Market Report 2025 - Product Thumbnail Image

Cancer Biopsy Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
Prostate Cancer - Competitive landscape, 2024 - Product Thumbnail Image

Prostate Cancer - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 450 Pages
  • Global
From
From
From
From
From
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • April 2025
  • 88 Pages
  • Global
From
Loading Indicator

Melanoma is a type of cancer that affects the skin and is the most serious form of skin cancer. It is caused by the uncontrolled growth of pigment-producing cells, known as melanocytes. Melanoma is the fifth most common cancer in the United States, with an estimated 87,110 new cases in 2020. It is also the leading cause of death from skin disease. The melanoma market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be driven by the increasing adoption of targeted therapies, immunotherapies, and combination therapies. Additionally, the increasing focus on personalized medicine and the development of novel drug delivery systems are expected to drive the market. Some of the key players in the melanoma market include Bristol-Myers Squibb, Merck & Co., Novartis, Roche, Pfizer, and Eli Lilly. Show Less Read more